CNS pipeline · person
John Glasspool
Director of Relmada Therapeutics since December 2019. He is CEO of VarmX B.V. and was previously CEO of Anthos Therapeutics, Executive Vice President at Baxalta (Baxter BioScience), and Head of Region Europe for Novartis Vaccines & Diagnostics. He holds degrees from the University of Staffordshire and Oxford University.
- 1 company
Courtesy Relmada Therapeutics
Current roles
- Relmada Therapeutics, Inc.Director · Board2019–present
Appears with
People sharing a company with John.
- Charles Ence · Relmada Therapeutics, Inc.
- Charles J. Casamento · Relmada Therapeutics, Inc.
- Fabiana Fedeli · Relmada Therapeutics, Inc.
- Maged Shenouda · Relmada Therapeutics, Inc.
- Max Kates · Relmada Therapeutics, Inc.
- Paul Kelly · Relmada Therapeutics, Inc.
- Raj S. Pruthi · Relmada Therapeutics, Inc.
- Sergio Traversa · Relmada Therapeutics, Inc.
- Yair Lotan · Relmada Therapeutics, Inc.
People and affiliation data assembled from public company disclosures, SEC filings, and conference materials — every record source-cited under psychiatrist-authored guardrails.